COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,952 Articles (22,604 medRxiv, 8,348 bioRxiv)

Most recent first Previous |  Page 2729: Articles 27281-27290  | Next

Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
Pique-Regi, R., Romero, R., Tarca, A. L., Luca, F., Xu, Y., Leng, Y., Hsu, C.-D., Gomez-Lopez, N.
10.1101/2020.05.18.101485 — Posted: 2020-05-18
Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19
Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Linty, F., Visser, R., Brinkhaus, M., Sustic, T., deTaeye, S. W., Bentlage, A. E. H., Nouta, J., Natunen, S., Koeleman, C. A. M., Sainio, S., Kootstra, N. A., Brouwer, P. J. M., Sanders, R. W., van Gils, M. J., de Bruin, S., Vlaar, A. P. J., Amsterdam UMC COVID-19 biobank study group, , Zaaijer, H. L., Wuhrer, M., van der Schoot, C. E., Vidarsson, G.
10.1101/2020.05.18.099507 — Posted: 2020-05-18
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Thoms, M., Buschauer, R., Ameismeier, M., Koepke, L., Denk, T., Hirschenberger, M., Kratzat, H., Hayn, M., Mackens-Kiani, T., Cheng, J., Stuerzel, C. M., Froehlich, T., Berninghausen, O., Becker, T., Kirchhoff, F., Sparrer, K. M. J., Beckmann, R.
10.1101/2020.05.18.102467 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Robot dance: a city-wise automatic control of Covid-19 mitigation levels
Silva, P. J. S., Pereira, T., Nonato, L. G.
10.1101/2020.05.11.20098541 — Posted: 2020-05-18 Discussion: Onsite
Estimating the true (population) infection rate for COVID-19: A Backcasting Approach with Monte Carlo Methods
Phipps, S. J., Grafton, R. Q., Kompas, T.
10.1101/2020.05.12.20098889 — Posted: 2020-05-18
No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium.
Desmet, S., Ekinci, E., Wouters, I., Decru, B., Beuselinck, K., Malhotra-Kumar, S., Theeten, H.
10.1101/2020.05.13.20095190 — Posted: 2020-05-18 Discussion: Onsite
Retrospective Pooled Screening for SARS-CoV-2 RNA in late 2019
Hogan, C. A., Garamani, N., Sahoo, M. K., Huang, C., Zehnder, J., Pinsky, B.
10.1101/2020.05.14.20102079 — Posted: 2020-05-18 Discussion: Onsite
Estimating the Global Infection Fatality Rate of COVID-19
Grewelle, R., De Leo, G.
10.1101/2020.05.11.20098780 — Posted: 2020-05-18 Discussion: Onsite
Behavioural change towards reduced intensity physical activity is disproportionately prevalent among adults with serious health issues or self-perception of high risk during the UK COVID-19 lockdown.
Rogers, N. T., Waterlow, N., Brindle, H. E., Enria, L., Eggo, R. M., Lees, S., Roberts, C. h.
10.1101/2020.05.12.20098921 — Posted: 2020-05-18
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak
Valenti, L., Bergna, A., Pelusi, S., Facciotti, F., Lai, A., Tarkowski, M., Berzuini, A., Caprioli, F., Santoro, L., Baselli, G., Della Ventura, C., Erba, E., Bosari, S., Galli, M., Zehender, G., Prati, D.
10.1101/2020.05.11.20098442 — Posted: 2020-05-18 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).